Pedro L. Delgado, MD

Douglas Danford Bond Professor and Chairman
Department of Psychiatry
Case Western Reserve University School of Medicine
University Hospitals of Cleveland
Cleveland, Ohio

Pedro L. Delgado, MD, MA, is the Douglas Bond Professor of Psychiatry and Chairman of the Department of Psychiatry, Case Western Reserve University and University Hospitals of Cleveland. He earned his MD with election into AOA and his MA in Pharmacology from the University of Texas in Galveston. His internship and residency in psychiatry were at Yale University following which he served for several years on the Yale faculty. He then moved to the University of Arizona, where he most recently was Professor, Associate Department Head, and Director of Research in the Department of Psychiatry.

Dr. Delgado is a skilled clinician whose research interests focus on the neurobiology and psychopharmacology of mood and anxiety disorders, depression, schizophrenia and other psychiatric conditions, mental health services, cross cultural aspects of mental illness. Dr. Delgado is most known for his groundbreaking work using tryptophan depletion and catecholamine depletion in the study of antidepressant drugs. His research is supported by two major NIH grants, a series of pharmaceutical-industry sponsored projects. He is a Diplomate of the American Board of Psychiatry and Neurology, a member of the American College of Neuropsychopharmacology, and current President of the American Society of Hispanic Psychiatry. He is a member of the NIH Behavioral and Biobehavioral Processes Study Section and serves on the editorial boards of many prominent psychiatric journals. He has published numerous original articles, reviews, abstracts and book chapters and is a frequent lecturer on biological aspects of depression and clinical use of antidepressant drugs.